A Canadian cancer specialist plans clinical trials for a pill that doubled survival time in preclinical studies, offering hope for pancreatic cancer patients.
A Canadian pancreatic cancer specialist announced plans to open clinical trials for a pill that has shown promising results in doubling survival time for patients.
The specialist, who has been studying the disease for over a decade, expressed optimism about the potential breakthrough. Pancreatic cancer is one of the deadliest forms of cancer, with a five-year survival rate of less than 10 percent. Current treatments often involve chemotherapy and surgery, but they offer limited effectiveness. The new pill, which has demonstrated significant results in early studies, works by targeting specific genetic mutations common in pancreatic tumors.
In preclinical trials, the drug doubled the survival time of lab animals, sparking hope for human applications. The upcoming clinical trials will involve a small group of patients to test safety and efficacy. If successful, this could lead to a paradigm shift in how pancreatic cancer is treated. The specialist emphasized the need for more funding and collaboration to accelerate research.
Meanwhile, patient advocacy groups have welcomed the news, urging health authorities to expedite the process. The announcement comes as Canada faces rising cancer rates, with pancreatic cancer being a leading cause of death. The specialist's team is now recruiting participants for the first phase of trials, expected to start later this year. This development offers a glimmer of hope for thousands of patients and their families
Please follow us on Google to support usPancreatic Cancer Clinical Trials Pill Survival Canada
Canada Latest News, Canada Headlines
Similar News: You can also read news stories similar to this one that we have collected from other news sources.
'Game changer' experimental drug doubles survival time for pancreatic cancer, trial showsAn experimental drug that doubles survival time for pancreatic cancer is being hailed as a breakthrough for combating one of the world's deadliest cancers.
Read more »
Canadian pancreatic cancer specialist expects to open clinical trials on pill that doubled survival timeTORONTO — The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill that could double survival time will soon be open to Canadian patients. Medical oncologist Dr.
Read more »
Canadian pancreatic cancer specialist expects to open clinical trials on pill that doubled survival timeTORONTO — The head of pancreatic cancer at Princess Margaret Cancer Centre says she hopes clinical trials for a pill that could double survival time will soon be open to Canadian patients. Medical oncologist Dr.
Read more »
Vegas Golden Knights celebrate goal in Stanley Cup Final as multiple stories cover local impacts and global eventsA collection of news stories includes coverage of the NHL Stanley Cup Final game between the Vegas Golden Knights and the Carolina Hurricanes, expert analysis on World Cup traffic in Toronto, a business owner's concerns after break-ins, windstorm aftermath costs, labor disputes at a locked-out Ontario plant, a Banff National Park closure following a rockfall, trade minister comments on CUSMA renewal, a Canadian specialist's pancreatic cancer clinical trials, a literary prize winner, Pope Leo's tennis routine, ancient yeast discovery, and various shopping trend reviews.
Read more »